TELA Bio, Inc. provided revenue guidance for the year 2024. For the year, the company expects Increased full year 2024 revenue guidance to $74.5 million to $76.5 million, representing 27% to 31% year-over-year growth.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 USD | +0.18% | -4.75% | -15.26% |
20/05 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
10/05 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.26% | 139M | |
-7.57% | 177B | |
-6.99% | 65.54B | |
-4.65% | 47.09B | |
+7.38% | 43.43B | |
+8.14% | 41.77B | |
+14.07% | 29.55B | |
+15.53% | 24.83B | |
-6.53% | 23.97B | |
-5.97% | 23.54B |
- Stock Market
- Equities
- TELA Stock
- News TELA Bio, Inc.
- TELA Bio, Inc. Provides Revenue Guidance for the Year 2024